mesenchymal cells derived exosomes
/ AbelZeta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 08, 2020
A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia
(clinicaltrials.gov)
- P1; N=24; Completed; Sponsor: Ruijin Hospital; Not yet recruiting ➔ Completed
Clinical • Trial completion • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
1 to 1
Of
1
Go to page
1